FDA: Physicians Shouldn't Cancel ERCP Procedures (FREE)

By Kristin J. Kelley

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS
The FDA says that it is not necessary for physicians to cancel endoscopic retrograde cholangiopancreatography (ERCP) procedures with one specific model of duodenoscope that's in use without the proper clearance for marketing. There is no evidence that …

Source: Physician's First Watch current issue - March 6, 2015 Category: Primary Care Source Type: news